Showing results (661-670 of 1,005) with videos related to

Sort By:
Pageof 101
Anti-Cancer Drugs|May 29, 2004
Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancersA Awada, T Gil, F Sales, et al.
Ecancermedicalscience|December 21, 2016
Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisationLinda Cairns, Sandrine Aspeslagh, Andrea Anichini, et al.
ACS Omega|June 22, 2026
Identification and Quantification of Gluconic, Metasaccharinic, Glyceric, Formic, and Acetic Acids as Novel Glucose Degradation Products in Peritoneal Dialysis FluidsSabrina Gensberger-Reigl, Jinan Awada, Vera L Rodrigues Guimarães Abreu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Phase I trial of sorafenib and gemcitabine in advanced solid tumors with an expanded cohort in advanced pancreatic cancerLillian L Siu, Ahmad Awada, Chris H Takimoto, et al.
Infectious Medicine|January 21, 2026
Antimicrobial resistance and virulence patterns of <i>Helicobacter pylori</i> among patients with suspected peptic ulcer disease in disenfranchised settingsMarwan Osman, Rayane Rafei, Kevin J Cummings, et al.
Neuroepidemiology|January 1, 1993
A community survey of neurological disorders in Saudi Arabia: the Thugbah studyS al Rajeh, O Bademosi, H Ismail, et al.
Journal of Clinical Pharmacology|September 22, 2006
Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancerSteven Zhang, Peter Zannikos, Ahmad Awada, et al.
Cell Reports|August 16, 2018
Blocking the FSTL1-DIP2A Axis Improves Anti-tumor ImmunityChie Kudo-Saito, Akiko Ishida, Yuji Shouya, et al.
Pharmacy Practice|October 8, 2015
Factors affecting medication adherence in Lebanese patients with chronic diseasesAmal Al-Hajje, Sanaa Awada, Samar Rachidi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 23, 2023
Integrative transcriptomics and cell systems analyses reveal protective pathways controlled by Igfbp-3 in anthracycline-induced cardiotoxicityJunjie Chen, Douglas J Chapski, Jeremy Jong, et al.
Pageof 101